April 8, 2026
April 8, 2026
Categories

ECOG-ACRIN vice chair Dr. Al Benson discusses the evolving role of first-line immunotherapy for advanced anal cancer, referencing the InterAACT-2 and EA2176 trials

Do you like it?
Read more
April 8, 2026
April 8, 2026
Categories

Group co-chair Dr. Mitchell Schnall named a health system chief digital officer to know in 2026

Do you like it?
Read more
March 30, 2026
March 30, 2026
Categories

The March 2026 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
March 24, 2026
March 24, 2026
Categories

ECOG-ACRIN study finds inferior survival among Black patients with AML, independent of cytogenetic risk

Do you like it?
Read more
February 27, 2026
February 27, 2026
Categories

Attention medical and research trainees: Applications are now being accepted for the Edith Peterson Mitchell, MD, Health Equity Travel Scholarship to attend the Spring 2026 Group Meeting

Do you like it?
Read more
February 9, 2026
February 9, 2026
Categories

Natasha Edwin, MD, community co-chair of the ECOG-ACRIN Myeloma Committee, highlights why patients in rural areas need access to quality clinical trials

Do you like it?
Read more
February 3, 2026
February 3, 2026
Categories

ECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations

Do you like it?
Read more
January 29, 2026
January 29, 2026
Categories

Press Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer

Do you like it?
Read more
January 21, 2026
January 21, 2026
Categories

ECOG-ACRIN study identifies high rates of vulnerability in AML patients aged 60 years or older

Do you like it?
Read more
Load more
ECOG-ACRIN Cancer Research Group